TrovaGene Inc. | Ownership
Companies that own TrovaGene Inc.
Sabby Capital LLC
750,550
4.24%
750,550
0.3%
06/30/2018
Heights Capital Management, Inc.
307,445
1.74%
266,700
0.01%
06/30/2018
Renaissance Technologies LLC
203,802
1.14%
193,079
0%
06/30/2018
Elkhorn Partners LP
89,168
0.5%
65,001
0.04%
06/30/2018
Security National Bank of Omaha (Private Banking)
41,200
0.23%
41,200
0.02%
06/30/2018
The Vanguard Group, Inc.
39,262
0.22%
-42,831
0%
06/30/2018
BlackRock Fund Advisors
33,275
0.19%
51
0%
06/30/2018
G1 Execution Services LLC
25,092
0.14%
21,362
0%
06/30/2018
Citadel Advisors LLC
23,513
0.13%
23,513
0%
06/30/2018
Two Sigma Securities LLC
16,000
0.09%
16,000
0%
06/30/2018
| Address |
11055 Flintkote Avenue
San Diego California 92121
United States
|
|
Employees
|
- |
| Website |
http://www.trovagene.com |
| Updated |
07/08/2019 |
| Trovagene, Inc. is a clinical-stage, precision medicine oncology therapeutics company. Its focuses on developing PCM-075, is a Polo-like Kinase 1 (PLK1) selective adenosine triphosphate (ATP) competitive inhibitor. The company was founded by Gabriel M. |
